WSTAM
TWST icon

Wilbanks Smith & Thomas Asset Management’s Twist Bioscience TWST Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,359
Closed -$415K – 538
2021
Q4 		$415K Buy
5,359
+2,135
+66% +$219K 0.01% 355
2021
Q3 		$345K Buy
+3,224
New +$369K 0.01% 358

Other funds holding TWST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wilbanks Smith & Thomas Asset Management's TWST Position: Q1 2022 in Review

Wilbanks Smith & Thomas Asset Management sold out of Twist Bioscience (TWST) in Q1 2022, closing a stake of 5,359 shares — an estimated $415K sold.

Wilbanks Smith & Thomas Asset Management first reported a position in TWST in Q3 2021 and held it in 2 quarters. The position peaked at $415K in Q4 2021. 212 funds tracked by Wall St. Rank hold TWST as of Q1 2022.

  • Wilbanks Smith & Thomas Asset Management reported no remaining Twist Bioscience position as of Q1 2022 after selling out during the quarter.
  • Wilbanks Smith & Thomas Asset Management sold 5,359 Twist Bioscience shares in Q1 2022, an estimated $415K.
  • Wilbanks Smith & Thomas Asset Management first reported a position in Twist Bioscience in Q3 2021 and held it in 2 quarters.
  • Wilbanks Smith & Thomas Asset Management's Twist Bioscience position peaked at $415K in Q4 2021.
  • 212 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2022.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q1 2022, filed 5 May 2022.